About zoster vaccine recombinant adjuvanted
Recombinant adjuvanted shingles vaccine
Used for
- Prevents shingles (herpes zoster) and related nerve pain in eligible adults.
Usual adult dose
Two injections into a muscle, usually 2–6 months apart. Some immunocompromised adults may receive the second dose after 1–2 months.
Common side effects
- Injection-site pain, redness, or swelling
- Muscle pain, tiredness, headache, chills, or fever
- Nausea or stomach upset
Important warnings
- Not for treating active shingles.
- Do not give after a severe allergic reaction to a previous dose or vaccine ingredient.
- Fainting can occur after vaccination; observation may be appropriate.
- Vaccination may be postponed during a serious acute illness.
Pregnancy
There are no adequate data in pregnant people; vaccination is generally deferred until after pregnancy.
Breastfeeding
It is unknown whether the vaccine passes into breast milk; discuss timing with a healthcare professional.
Interactions
- May be given with certain other vaccines at separate injection sites.
- Immune-suppressing treatments may reduce the vaccine response.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.